Company Filing History:
1 out of 262 
1 out of 51 
1 out of 123 
Years Active: 2009
Title: Catherine Gaulon: Innovator in Therapeutic Compounds
Introduction
Catherine Gaulon is a notable inventor based in Le Mans, France. She has made significant contributions to the field of therapeutic compounds, particularly in the area of cancer treatment. Her innovative work has led to the development of compounds that inhibit critical pathways involved in cell proliferation.
Latest Patents
Catherine Gaulon holds a patent for "Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds." This invention pertains to specific compounds that inhibit RAF (e.g., B-RAF) activity, which is crucial in the treatment of various cancers, including colorectal cancer and melanoma. The patent outlines the chemical structures and potential applications of these compounds in pharmaceutical compositions.
Career Highlights
Throughout her career, Catherine has worked with esteemed organizations such as Cancer Research Technology Limited and the Institute of Cancer Research: Royal Cancer Hospital. Her work has focused on developing innovative solutions to combat cancer and improve patient outcomes.
Collaborations
Catherine has collaborated with notable colleagues, including Dan Niculescu-Duvaz and Caroline Joy Springer. These partnerships have contributed to her research and the advancement of therapeutic strategies in oncology.
Conclusion
Catherine Gaulon's contributions to the field of therapeutic compounds exemplify her dedication to cancer research and innovation. Her patented work continues to influence the development of effective treatments for cancer patients.